Rapid Micro Biosystems, Inc. (RPID) financial statements (2022 and earlier)

Company profile

Business Address 1001 PAWTUCKET BLVD.
LOWELL, MA 01854
State of Incorp. MA
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments193,497
Cash and cash equivalents178,387
Short-term investments15,110
Receivables5,005
Inventory, net of allowances, customer advances and progress billings15,671
Inventory15,671
Prepaid expense1,622
Contract with customer, asset396
Deposits current assets1,262
Other current assets440
Other undisclosed current assets231
Total current assets:218,124
Noncurrent Assets
Property, plant and equipment11,304
Long-term investments and receivables9,966
Long-term investments9,966
Restricted cash and investments284
Other noncurrent assets1,491
Total noncurrent assets:23,045
TOTAL ASSETS:241,169
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,861
Accounts payable3,944
Accrued liabilities10,917
Deferred revenue3,305
Total current liabilities:18,166
Noncurrent Liabilities
Liabilities, other than long-term debt1,210
Other liabilities1,210
Other undisclosed noncurrent liabilities813
Total noncurrent liabilities:2,023
Total liabilities:20,189
Stockholders' equity
Stockholders' equity attributable to parent, including:220,980
Additional paid in capital535,693
Accumulated other comprehensive loss(16)
Accumulated deficit(315,112)
Other undisclosed stockholders' equity attributable to parent415
Total stockholders' equity:220,980
TOTAL LIABILITIES AND EQUITY:241,169

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues23,232
Cost of revenue(30,991)
Gross profit:(7,759)
Operating expenses(39,473)
Operating loss:(47,232)
Nonoperating expense(26,201)
Interest and debt expense(3,100)
Loss from continuing operations before equity method investments, income taxes:(76,533)
Other undisclosed income from continuing operations before income taxes3,100
Loss from continuing operations before income taxes:(73,433)
Income tax expense(91)
Net loss attributable to parent:(73,524)
Preferred stock dividends and other adjustments(4,508)
Net loss available to common stockholders, diluted:(78,032)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(73,524)
Comprehensive loss:(73,524)
Other undisclosed comprehensive loss, net of tax, attributable to parent(17)
Comprehensive loss, net of tax, attributable to parent:(73,541)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: